share_log

Virpax Pharmaceuticals Q2 EPS $(0.50) Down From $(0.47) YoY

Virpax Pharmaceuticals Q2 EPS $(0.50) Down From $(0.47) YoY

Virpax製藥公司第二季度每股收益為0.50美元,低於去年同期的0.47美元
Benzinga Real-time News ·  2022/08/15 09:06

Virpax Pharmaceuticals (NASDAQ:VRPX) reported quarterly losses of $(0.50) per share. This is a 6.38 percent decrease over losses of $(0.47) per share from the same period last year.

納斯達克(VRPX:VRPX)公佈季度每股虧損0.5美元。這比去年同期每股虧損0.47美元減少了6.38%。

声明:本內容僅用作提供資訊及教育之目的,不構成對任何特定投資或投資策略的推薦或認可。 更多信息
    搶先評論